Shelter Pharma Limited has appointed Financial Mindss as its Investor Relations and Public Relations agency, marking a strategic move to enhance its communication and stakeholder engagement capabilities. The appointment was formally communicated to BSE Limited on March 13, 2026, in compliance with regulatory requirements.

Appointment Details

The company has engaged Financial Mindss, operating under the corporate name Jai Bharti Capital Advisory Private Limited, to serve as its dedicated IR and PR agency. The appointment was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Service Scope and Objectives

Financial Mindss will provide comprehensive Investor and Public Relations Advisory Services to Shelter Pharma Limited. The agency's mandate encompasses several key areas designed to strengthen the company's external communication framework.

The services will focus on:

• Strengthening investor communication framework
• Enhanced stakeholder engagement initiatives
• Comprehensive media relations management
• Development of overall public relations strategy

Regulatory Compliance

The appointment notification was submitted to BSE Limited under Script Code 543963, ensuring full compliance with listing obligations. Managing Director Mustaqim Nisarahmed Sabugar signed the formal communication, which was digitally authenticated and submitted from the company's Ahmedabad office.

This strategic appointment reflects Shelter Pharma's commitment to maintaining transparent and effective communication channels with its investors and stakeholders while ensuring adherence to regulatory disclosure requirements.

Shelter Pharma Limited has secured a significant international order worth $18,300 from First Vet Veterinary Medicines Trading LLC, UAE, for the supply of veterinary and animal healthcare products. The company announced this development on March 12, 2024, in compliance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015.

Order Details and Specifications

The contract represents a fixed-cost arrangement with the UAE-based veterinary medicines trading company, with execution scheduled within 6 months. The order focuses on veterinary and animal healthcare products, expanding Shelter Pharma's international footprint in the animal health segment.

Regulatory Compliance and Corporate Governance

Shelter Pharma Limited has confirmed that this transaction maintains high standards of corporate governance. The company disclosed that promoters and promoter group companies have no interest in the entity that awarded the order. Additionally, the contract does not fall within related party transactions, ensuring arm's length dealing principles.

About Shelter Pharma Limited

Shelter Pharma Limited operates as a leading pharmaceutical and nutraceutical company with a strong focus on research, innovation, and quality. The company maintains state-of-the-art facilities and employs a world-class team of experts committed to ethical practices. Founded with a vision to provide accessible and effective healthcare solutions, Shelter Pharma has established itself as a trusted name in the industry by consistently delivering products that adhere to the highest industry standards.

The company's mission centers on promoting well-being and health through innovative, high-quality nutraceuticals. Shelter Pharma takes pride in its recognition for producing safe and effective products that enhance quality of life for individuals globally, guided by strong ethical codes and deep social responsibility.